MERCK & CO. INC. (6MK.DE) Stock Price & Overview

FRA:6MK • US58933Y1055

102.6 EUR
-0.4 (-0.39%)
Last: Mar 4, 2026, 07:00 PM

The current stock price of 6MK.DE is 102.6 EUR. Today 6MK.DE is down by -0.39%. In the past month the price increased by 1.18%. In the past year, price increased by 15.28%.

6MK.DE Key Statistics

52-Week Range65.5 - 106
Current 6MK.DE stock price positioned within its 52-week range.
1-Month Range97.4 - 106
Current 6MK.DE stock price positioned within its 1-month range.
Market Cap
254.655B
P/E
12.97
Fwd P/E
22.01
EPS (TTM)
7.91
Dividend Yield
2.85%

6MK.DE Stock Performance

Today
-0.39%
1 Week
-1.72%
1 Month
+1.18%
3 Months
+19.58%
Longer-term
6 Months +42.30%
1 Year +15.28%
2 Years -15.90%
3 Years +5.34%
5 Years +55.93%
10 Years N/A

6MK.DE Stock Chart

MERCK & CO. INC. / 6MK Daily stock chart

6MK.DE Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to 6MK.DE. When comparing the yearly performance of all stocks, 6MK.DE is one of the better performing stocks in the market, outperforming 80.94% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
6MK.DE Full Technical Analysis Report

6MK.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 6MK.DE. While 6MK.DE has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
6MK.DE Full Fundamental Analysis Report

6MK.DE Earnings

On February 3, 2026 6MK.DE reported an EPS of 2.09 and a revenue of 16.40B. The company beat EPS expectations (2.98% surprise) and beat revenue expectations (0.31% surprise).

Next Earnings DateApr 30, 2026
Last Earnings DateFeb 3, 2026
PeriodQ4 / 2025
EPS Reported$2.09
Revenue Reported16.4B
EPS Surprise 2.98%
Revenue Surprise 0.31%
6MK.DE Earnings History

6MK.DE Forecast & Estimates

34 analysts have analysed 6MK.DE and the average price target is 108.2 EUR. This implies a price increase of 5.46% is expected in the next year compared to the current price of 102.6.

For the next year, analysts expect an EPS growth of -41.06% and a revenue growth 2.98% for 6MK.DE


Analysts
Analysts77.06
Price Target108.2 (5.46%)
EPS Next Y-41.06%
Revenue Next Year2.98%
6MK.DE Forecast & Estimates

6MK.DE Groups

Sector & Classification

6MK.DE Financial Highlights

Over the last trailing twelve months 6MK.DE reported a non-GAAP Earnings per Share(EPS) of 7.91. The EPS increased by 20.16% compared to the year before.


Income Statements
Revenue(TTM)65.01B
Net Income(TTM)19.03B
Industry RankSector Rank
PM (TTM) 29.63%
ROA 14.69%
ROE 36.71%
Debt/Equity 0.77
Chartmill High Growth Momentum
EPS Q2Q%21.51%
Sales Q2Q%4.97%
EPS 1Y (TTM)20.16%
Revenue 1Y (TTM)1.31%
6MK.DE financials

6MK.DE Ownership

Ownership
Inst Owners80.32%
Shares2.48B
Float2.48B
Ins Owners0.05%
Short Float %N/A
Short RatioN/A
6MK.DE Ownership

6MK.DE Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SNW SANOFI9.38193.005B
1SAN SANOFI9.38192.909B
SAN SANOFI9.37192.885B
MRK MERCK KGAA14.3252.761B
UCB UCB SA25.5849.192B
UNC UCB SA25.5848.413B
1BAYN BAYER AG-REG7.6737.921B
BAYN BAYER AG-REG7.6637.637B
IPN IPSEN14.3513.477B
REC RECORDATI INDUSTRIA CHIMICA16.5510.03B
TUB FINANCIERE DE TUBIZE N/A9.725B
VIRP VIRBAC SA16.442.932B
DMP DERMAPHARM HOLDING SE15.32.046B

About 6MK.DE

Company Profile

6MK logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Company Info

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY US

Employees: 75000

6MK Company Website

6MK Investor Relations

Phone: 19087404000

MERCK & CO. INC. / 6MK.DE FAQ

Can you describe the business of MERCK & CO. INC.?

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.


What is the current price of 6MK stock?

The current stock price of 6MK.DE is 102.6 EUR. The price decreased by -0.39% in the last trading session.


Does 6MK stock pay dividends?

MERCK & CO. INC. (6MK.DE) has a dividend yield of 2.85%. The yearly dividend amount is currently 2.77.


What is the ChartMill rating of MERCK & CO. INC. stock?

6MK.DE has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What sector and industry does MERCK & CO. INC. belong to?

MERCK & CO. INC. (6MK.DE) operates in the Health Care sector and the Pharmaceuticals industry.


Who owns MERCK & CO. INC.?

You can find the ownership structure of MERCK & CO. INC. (6MK.DE) on the Ownership tab.